The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase Ib study of decitabine in combination with gemcitabine in treatment of advanced soft tissue and bone sarcomas.
 
Varun Monga
Consulting or Advisory Role - Forma Therapeutics
Research Funding - ImmunoCellular Therapeutics (Inst); Newlink Genetics (Inst); Orbus Therapeutics (Inst)
Travel, Accommodations, Expenses - Deciphera (Inst); GlaxoSmithKline (Inst)
 
Rebecca Dodd
No Relationships to Disclose
 
Amanda Scherer
No Relationships to Disclose
 
Wade Robert Gutierrez
No Relationships to Disclose
 
Munir Tanas
No Relationships to Disclose
 
Sarah L. Mott
No Relationships to Disclose
 
Mohammed M. Milhem
Honoraria - Amgen; Array BioPharma; Blueprint Medicines; Immunocore; Novartis; Trieza Therapeutics
Consulting or Advisory Role - Amgen; Array BioPharma; Blueprint Medicines; Immunocore; Novartis; Trieza Therapeutics
Research Funding - Amgen (Inst); E.R. Squibb Sons, LLC (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Prometheus (Inst)